“Isolated” elevation of alkaline phosphatase

Significance in hospitalized patients

David Lieberman, Daniel Phillips

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The significance of alkaline phosphatase (AP) elevation with otherwise normal transaminase and bilirubin values remains unclear. We evaluated the clinical outcome of hospitalized patients with an “isolated” AP elevation. Eighty-seven inpatients with isolated AP elevation were identified during February 1984 and followed for 1 year. Forty-five of 87 patients had normalization of AP during the follow-up period, usually within 1–3 months. The most common diagnoses in this group were congestive heart failure in nine, benign bone disease in six, and treatable malignancy in three patients. Twelve patients had no apparent explanation for the transient rise of AP. Persistent AP elevations were noted in 42 patients—14 of whom had terminal malignancies. Clinically obvious life-threatening diagnoses wee made in 24 of the patients with persistent AP elevation. The etiology of AP elevation remained enigmatic in seven patients: two died, four are stable during 1½-3 years of follow-up, and one patient was found to have metastatic carcinoma 17 months later. If the initial AP was greater than 1½ times normal, there was a higher likelihood of persistent elevation (68% vs. 41%, p <0.05). Isolated elevations of AP in inpatients may be associated with a variety of medical illnesses and often normalize within months. If the AP elevation is persistent, there is usually a clinically obvious diagnosis. A reasonable approach to such patients is a careful history, physical exam, and routine lab studies to detect obvious diagnoses, followed by repeat enzyme determination at 1–3 months.

Original languageEnglish (US)
Pages (from-to)415-419
Number of pages5
JournalJournal of Clinical Gastroenterology
Volume12
Issue number4
StatePublished - 1990

Fingerprint

Alkaline Phosphatase
Inpatients
Bone Diseases
Transaminases
Bilirubin
Neoplasms
Heart Failure
History
Carcinoma
Enzymes

Keywords

  • Alkaline phosphatase

ASJC Scopus subject areas

  • Gastroenterology

Cite this

“Isolated” elevation of alkaline phosphatase : Significance in hospitalized patients. / Lieberman, David; Phillips, Daniel.

In: Journal of Clinical Gastroenterology, Vol. 12, No. 4, 1990, p. 415-419.

Research output: Contribution to journalArticle

@article{9986ef2e8fd548809affc5271cd0b674,
title = "“Isolated” elevation of alkaline phosphatase: Significance in hospitalized patients",
abstract = "The significance of alkaline phosphatase (AP) elevation with otherwise normal transaminase and bilirubin values remains unclear. We evaluated the clinical outcome of hospitalized patients with an “isolated” AP elevation. Eighty-seven inpatients with isolated AP elevation were identified during February 1984 and followed for 1 year. Forty-five of 87 patients had normalization of AP during the follow-up period, usually within 1–3 months. The most common diagnoses in this group were congestive heart failure in nine, benign bone disease in six, and treatable malignancy in three patients. Twelve patients had no apparent explanation for the transient rise of AP. Persistent AP elevations were noted in 42 patients—14 of whom had terminal malignancies. Clinically obvious life-threatening diagnoses wee made in 24 of the patients with persistent AP elevation. The etiology of AP elevation remained enigmatic in seven patients: two died, four are stable during 1½-3 years of follow-up, and one patient was found to have metastatic carcinoma 17 months later. If the initial AP was greater than 1½ times normal, there was a higher likelihood of persistent elevation (68{\%} vs. 41{\%}, p <0.05). Isolated elevations of AP in inpatients may be associated with a variety of medical illnesses and often normalize within months. If the AP elevation is persistent, there is usually a clinically obvious diagnosis. A reasonable approach to such patients is a careful history, physical exam, and routine lab studies to detect obvious diagnoses, followed by repeat enzyme determination at 1–3 months.",
keywords = "Alkaline phosphatase",
author = "David Lieberman and Daniel Phillips",
year = "1990",
language = "English (US)",
volume = "12",
pages = "415--419",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - “Isolated” elevation of alkaline phosphatase

T2 - Significance in hospitalized patients

AU - Lieberman, David

AU - Phillips, Daniel

PY - 1990

Y1 - 1990

N2 - The significance of alkaline phosphatase (AP) elevation with otherwise normal transaminase and bilirubin values remains unclear. We evaluated the clinical outcome of hospitalized patients with an “isolated” AP elevation. Eighty-seven inpatients with isolated AP elevation were identified during February 1984 and followed for 1 year. Forty-five of 87 patients had normalization of AP during the follow-up period, usually within 1–3 months. The most common diagnoses in this group were congestive heart failure in nine, benign bone disease in six, and treatable malignancy in three patients. Twelve patients had no apparent explanation for the transient rise of AP. Persistent AP elevations were noted in 42 patients—14 of whom had terminal malignancies. Clinically obvious life-threatening diagnoses wee made in 24 of the patients with persistent AP elevation. The etiology of AP elevation remained enigmatic in seven patients: two died, four are stable during 1½-3 years of follow-up, and one patient was found to have metastatic carcinoma 17 months later. If the initial AP was greater than 1½ times normal, there was a higher likelihood of persistent elevation (68% vs. 41%, p <0.05). Isolated elevations of AP in inpatients may be associated with a variety of medical illnesses and often normalize within months. If the AP elevation is persistent, there is usually a clinically obvious diagnosis. A reasonable approach to such patients is a careful history, physical exam, and routine lab studies to detect obvious diagnoses, followed by repeat enzyme determination at 1–3 months.

AB - The significance of alkaline phosphatase (AP) elevation with otherwise normal transaminase and bilirubin values remains unclear. We evaluated the clinical outcome of hospitalized patients with an “isolated” AP elevation. Eighty-seven inpatients with isolated AP elevation were identified during February 1984 and followed for 1 year. Forty-five of 87 patients had normalization of AP during the follow-up period, usually within 1–3 months. The most common diagnoses in this group were congestive heart failure in nine, benign bone disease in six, and treatable malignancy in three patients. Twelve patients had no apparent explanation for the transient rise of AP. Persistent AP elevations were noted in 42 patients—14 of whom had terminal malignancies. Clinically obvious life-threatening diagnoses wee made in 24 of the patients with persistent AP elevation. The etiology of AP elevation remained enigmatic in seven patients: two died, four are stable during 1½-3 years of follow-up, and one patient was found to have metastatic carcinoma 17 months later. If the initial AP was greater than 1½ times normal, there was a higher likelihood of persistent elevation (68% vs. 41%, p <0.05). Isolated elevations of AP in inpatients may be associated with a variety of medical illnesses and often normalize within months. If the AP elevation is persistent, there is usually a clinically obvious diagnosis. A reasonable approach to such patients is a careful history, physical exam, and routine lab studies to detect obvious diagnoses, followed by repeat enzyme determination at 1–3 months.

KW - Alkaline phosphatase

UR - http://www.scopus.com/inward/record.url?scp=0025356261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025356261&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 415

EP - 419

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 4

ER -